Interestingly, Western blot analyses at two different time points 3 and 5 days after transduction revealed a marked reduction of FAK phosphorylation at Y397 for the SOX2-depleted glioma cells when compared to shLuc-transduced controls (Figure 5b). The gene discussed is SOX2; the disease is central nervous system cancer.